In today’s world, customers are bombarded with advertisements everywhere they turn. Open any social media platform, and there they are. Check your email inbox, and there are more of them.
Pharmaceutical and medical device manufacturers launching their first product in the US face several complex challenges while preparing for the required collection and reporting of transfer
Novel therapies, often with expensive price tags and finite patient populations, require strategic new positioning if they are to have maximum positive impact.
Although it might seem like AI is the newest and hottest innovation in the industry, medical affairs professionals have been using some form of it for decades
BeiGene has claimed a second EU approval for PD-1 inhibitor tislelizumab in non-small cell lung cancer (NSCLC), opening the door to the first launches of the drug outside
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.